Pharmacological treatments that facilitate extinction of fear: Relevance to psychotherapy

Rodrigues SM, Schafe GE, LeDoux JE. Molecular mechanisms underlying emotional learning and memory in the lateral amygdala. Neuron 44: 75–91, 2004. Aggleton JP. The amygdala. New York: Oxford University Press, 2000. Herman JL. Trauma and recovery. New York: BasicBooks, 1992. Gale GD, Anagnostaras SG, Godsil BP, Mitchell S, et al. Role of the basolateral amygdala in the storage of fear memories across the adult lifetime of rats. J Neurosci 24: 3810–3815, 2004. Rescorla RA, Wagner AR. A theory of Pavlovian conditioning: variations in the effectiveness of reinforcement and nonreinforcement. In: Classical conditioning II (Black A, Prokasy W, eds), pp 64–99. New York: Appleton-Century-Crofts, 1972. Hawkins RD, Kandel ER. Is there a cell-biological alphabet for simple forms of learning? Psychol Rev 91: 375–391, 1984. Robbins S. Mechanisms underlying spontaneous recovery in autoshaping. J Exp Psychol Anim Behav Process 16: 235–249, 1990. Bouton ME, Bolles RC. Role of conditioned contextual stimuli in reinstatement of extinguished fear. J Exp Psychol Anim Behav Process 5: 368–378, 1979. Rescorla RA, Heth CD. Reinstatement of fear to an extinguished conditioned stimulus. J Exp Psychol Anim Behav Process 1: 88–96, 1975. McSweeney FK, Swindell S. Common processes may contribute to extinction and habituation. J Gen Psychol 129: 364–400, 2002. Davis M, File SE. Intrinsic and extrinsic habituation and sensitization: implications for the design and interpretation of experiments. In: Habituation and the behaving organism (Peeke H, Petrinovich L, eds), pp 287–323. New York: Academic Press, 1984. Marlin NA, Miller RR. Associations to contextual stimuli as a determinant of long-term habituation. J Exp Psychol Anim Behav Process 7: 313–333, 1981. Bouton ME. Context, time, and memory retrieval in the interference paradigms of Pavlovian learning. Psychol Bull 114: 80–99, 1993. Konorski J. Conditioned reflexes and neuronal organization. London: Cambridge University Press, 1948. Pavlov I. Conditioned reflexes. Oxford: Oxford University Press, 1927. Wagner AR. SOP: a model of automatic memory processing in animal behavior. In: Information processing in animals: memory mechanisms (Spear N, ed). Hillside, NJ: Lawrence Erlbaum Associates, 1981. Cain CK, Blouin AM, Barad M. L-type voltage-gated calcium channels are required for extinction, but not for acquisition or expression, of conditional fear in mice. J Neurosci 22: 9113–9121, 2002. Falls WA, Miserendino MJ, Davis M. Extinction of fear potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci 12: 854–863, 1992. Szapiro G, Vianna MR, McGaugh JL, Medina JH, et al. The role of NMDA glutamate receptors, PKA, MAPK and CaMKII in the hippocampus in extinction of conditioned fear. Hippocampus 13: 53–58, 2003. Santini E, Ge H, Ren K, Pena de Ortiz S, et al. Consolidation of fear extinction requires protein synthesis in the medial prefrontal cortex. J Neurosci 24: 5704–5710, 2004. Lattal KM, Abel T. Different requirements for protein synthesis in acquisition and extinction of spatial preferences and context-evoked fear. J Neurosci 21: 5773–5880, 2001. Repa JC, Muller J, Apergis J, Desrochers TM, et al. Two different lateral amygdala cell populations contribute to the initiation and storage of memory. Nat Neurosci 4: 724–731, 2001. Hobin JA, Goosens KA, Maren S. Context-dependent neuronal activity in the lateral amygdala represents fear memories after extinction. J Neurosci 23: 8410–8416, 2003. Quirk GJ, Russo GK, Barron JL, Lebron K. The role of ventro-medial prefrontal cortex in the recovery of extinguished fear. J Neurosci 20: 6225–6231, 2000. Myers KM, Davis M. Behavioral and neural analysis of extinction. Neuron 36: 567–584, 2002. Schafe GE, Nader K, Blair HT, LeDoux JE. Memory consolidation of Pavlovian fear conditioning: a cellular and molecular perspective. Trends Neurosci 24: 540–546, 2001. Lin CH, Lee CC, Gean PW. Involvement of a calcineurin cascade in amygdala depotentiation and quenching of fear memory. Mol Pharmacol 63: 44–52, 2003. Lin CH, Yeh SH, Leu TH, Chang WC, et al. Identification of calcineurin as a key signal in the extinction of fear memory. J Neurosci 23: 1574–1579, 2003. Castellano C, McGaugh JL. Retention enhancement with posttraining picrotoxin: lack of state dependency. Behav Neural Biol 51: 165–170, 1989. McGaugh JL, Introini-Collison IB, Nagahara AH, Cahill L, et al. Involvement of the amygdaloid complex in neuromodulatory influences on memory storage. Neurosci Biobehav Rev 14: 425–431, 1990. Izquierdo I, Pereira ME. Post-training memory facilitation blocks extinction but not retroactive interference. Behav Neural Biol 51: 108–113, 1989. Overton D. Experimental methods for the study of state-dependent learning. Fed Proc 33: 1800–1813, 1974. Bouton ME, Kenney FA, Rosengard C. State-dependent fear extinction with two benzodiazepine tranquilizers. Behav Neurosci 104: 44–55, 1990. Castellano C, McGaugh JL. Effects of post-training bicuculline and muscimol on retention: lack of state dependency. Behav Neural Biol 54: 156–164, 1990. Harris JA, Westbrook RF. Evidence that GABA transmission mediates context-specific extinction of learned fear. Psychopharmacology (Berl) 140: 105–115, 1998. Chhatwal JP, Myers KM, Ressler KJ, Davis M. Regulation of gephyrin and GABAA receptor binding within the amygdala after fear acquisition and extinction. J Neurosci 25: 502–506, 2005. Ressler KJ, Paschall G, Zhou XL, Davis M. Regulation of synaptic plasticity genes during consolidation of fear conditioning. J Neurosci 22: 7892–902, 2002. Carlson PJ, Singh JB, Zarate CA Jr, Drevets WC, Manji HK. Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx 3: 22–41, 2006. Pittenger C, Krystal JH, Coric V. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx 3: 69–81, 2006. Miserendino MJD, Sananes CB, Melia KR, Davis M. Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature 345: 716–718, 1990. Kehoe E, Macrae M, Hutchinson C. MK-801 protects conditioned response from extinction in the rabbit nictitating membrane preparation. Psychobiology 24: 127–135, 1996. Lee H, Kim J. Amygdalar NMDA receptors are critical for new fear learning in previously fear-conditioned rats. J Neurosci 18: 8444–8454, 1998. Baker JD, Azorlosa JL. The NMDA antagonist MK-801 blocks the extinction of Pavlovian fear conditioning. Behav Neurosci 110: 618–620, 1996. Cox J, Westbrook R. The NMDA receptor antagonist MK-801 blocks acquisition and extinction of conditioned hypoalgesia responses in the rat. Q J Exp Psychol 47B: 187–210, 1994. Santini E, Muller RU, Quirk GJ. Consolidation of extinction learning involves transfer from NMDA-independent to NMDA-dependent memory. J Neurosci 21: 9009–9017, 2001. Walker DL, Ressler KJ, Lu KT, Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of d-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci 22: 2343–2351, 2002. Ledgerwood L, Richardson R, Cranney J. Effects of d-cycloserine on extinction of conditioned freezing. Behav Neurosci 117: 341–349, 2003. Ledgerwood L, Richardson R, Cranney J. d-Cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement. Behav Neurosci 118: 505–513, 2004. Porter AC, Felder CC. The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol Ther 90: 45–60, 2001. Kathuria S, Gaetani S, Fegley D, Valino F, et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9: 76–81, 2003. Katona I, Sperlagh B, Sik A, Kafalvi A, et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19: 4544–4558, 1999. Freund TF, Hajos N. Excitement reduces inhibition via endocannabinoids. Neuron 38: 362–365, 2003. Simon AB, Gorman JM. Advances in the treatment of anxiety: targeting glutamate. NeuroRx 3: 57–68, 2006. Haller J, Bakos N, Szirmay M, Ledent C, et al. The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur J Neurosci 16: 1395–1398, 2002. Marsicano G, Wotjak CT, Azad SC, Bisogno T, et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530–534, 2002. Chhatwal JP, Davis M, Maguschak KA, Ressler KJ. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology 30: 516–524, 2005. Willick ML, Kokkinidis L. Cocaine enhances the expression of fear potentiated startle: evaluation of state-dependent extinction and the shock sensitization of acoustic startle. Behav Neurosci 109: 929–938, 1995. El-Ghundi M, O’Dowd BF, George SR. Prolonged fear responses in mice lacking dopamine D1 receptor. Brain Res 892: 86–93, 2001. Nader K, LeDoux JE. Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations. Behav Neurosci 113: 891–901, 1999. Ponnusamy R, Nissim HA, Barad M. Systemic blockade of D2-like dopamine receptors facilitates extinction of conditioned fear in mice. Learn Mem 12: 399–406, 2005. McGaugh JL, Cahill L, Roozendaal B. Involvement of the amygdala in memory storage: interaction with other brain systems. Proc Natl Acad Sci USA 93: 13508–13514, 1996. McGaugh JL. Memory—a century of consolidation. Science 287: 248–251, 2000. Cain CK, Blouin AM, Barad M. Adrenergic transmission facilitates extinction of conditional fear in mice. Learn Mem 11: 179–187, 2004. Berman DE, Dudai Y. Memory extinction, learning anew, and learning the new: dissociations in the molecular machinery of learning in cortex. Science 291: 2417–2419, 2001. Bisson JI. Post-traumatic stress counselling. Br J Hosp Med 57: 112, 1997. Mayou RA, Ehlers A, Hobbs M. Psychological debriefing for road traffic accident victims. Three-year follow-up of a randomised controlled trial. Br J Psychiatry 176: 589–593, 2000. Rose S, Bisson JI, Churchill R, Wessely S. Psychological debriefing for preventing posttraumatic stress disorder (PTSD). Cochrane Database Syst Rev 2: CD000560, 2001. Southwick SM, Morgan A, Nagy LM, Bremner D, et al. Trauma related symptoms in veterans of Operation Desert Storm: a preliminary report. Am J Psychiatry 150: 1524–1528, 1993. Charney DS, Woods SW, Goodman WK, Heninger GR. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry 144: 1030–1036, 1987. Southwick SM, Krystal JH, Morgan CA, Johnson D, et al. Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry 50: 266–274, 1993. Ledgerwood L, Richardson R, Cranney J. d-Cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction. Biol Psychiatry 57: 841–847, 2005. Rescorla RA. Effect of US habituation following conditioning. J Comp Physiol Psychol 82: 137–143, 1973. Richardson R, Ledgerwood L, Cranney J. Facilitation of fear extinction by d-cycloserine: theoretical and clinical implications. Learn Mem 11: 510–516, 2004. Denniston J, Chang R, Miller R. Massive extinction treatment attenuates the renewal effect. Learn Motiv 34: 68–86, 2003. Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, et al. Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 61: 1136–1144, 2004. Rothbaum BO, Hodges LF, Kooper R, Opdyke D, et al. Effectiveness of computer-generated (virtual reality) graded exposure in the treatment of acrophobia. Am J Psychiatry 152: 626–628, 1995. Rothbaum BO, Hodges LF, Ready D, Graap K, et al. Virtual reality exposure therapy for Vietnam veterans with posttraumatic stress disorder. J Clin Psychiatry 62: 617–622, 2001. Rothbaum BO, Schwartz AC. Exposure therapy for posttraumatic stress disorder. Am J Psychother 56: 59–75, 2002. Rothbaum BO, Hodges L, Kooper R. Virtual reality exposure therapy. J Psychother Pract Res 6: 219–226, 1997. Baxter M, Lanthorn T, Frick K, Golski S, et al. d-Cycloserine, a novel cognitive enhancer, improves spatial memory in aged rats. Neurobiol Aging 15: 207–213, 1994. Quartermain D, Mower J, Rafferty M, Herting R, et al. Acute but not chronic activation of the NMDA-coupled glycine receptor with d-cycloserine facilitates learning and retention. Eur J Pharmacol 257: 7–12, 1994. Schuster GM, Schmidt WJ. d-Cycloserine reverses the working memory impairment of hippocampal-lesioned rats in a spatial learning task. Eur J Pharmacol 224: 97–98, 1992. Thompson LT, Moskal JR, Disterhoft JF. Hippocampus dependent learning facilitated by a monoclonal antibody or d-cycloserine. Nature 359: 638–641, 1992. Schwartz BL, Hashtroudi S, Herting RL, Schwartz P, et al. d-Cycloserine enhances implicit memory in Alzheimer patients. Neurology 46: 420–424, 1996. Tsai G, Falk W, Gunther J. A preliminary study of D-cycloserine treatment in Alzheimer’s disease. JNeuropsychiatry Clin Neurosci 10: 224–226, 1998. Laake K, Oeksengaard AR. d-Cycloserine for Alzheimer’s disease. Cochrane Database Syst Rev 2: CD003153, 2002. Randolph C, Roberts J, Tierney M, Bravi D, et al. d-Cycloserine treatment of Alzheimer’s disease. Alzheimers Dis Assoc Disord 8: 198–205, 1994. Fakouhi T, Jhee S, Sramek J, Benes C, et al. Evaluation of cycloserine in the treatment of Alzheimer’s disease. J Geriatric Psych Neurol 8: 226–230, 1995. Parnas AS, Weber M, Richardson R. Effects of multiple exposures to d-cycloserine on extinction of conditioned fear in rats. Neurobiol Learn Mem 83: 224–231, 2005.